BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24943831)

  • 1. Structure-based design of new KSP-Eg5 inhibitors assisted by a targeted multicomponent reaction.
    Carbajales C; Prado MÁ; Gutiérrez-de-Terán H; Cores A; Azuaje J; Novio S; Nuñez MJ; Fernández-García B; Sotelo E; García-Mera X; Sánchez-Lazo P; Freire-Garabal M; Coelho A
    Chembiochem; 2014 Jul; 15(10):1471-80. PubMed ID: 24943831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and bioevaluation of dihydropyrazolo[3,4-b]pyridine and benzo[4,5]imidazo[1,2-a]pyrimidine compounds as dual KSP and Aurora-A kinase inhibitors for anti-cancer agents.
    Fu RG; You QD; Yang L; Wu WT; Jiang C; Xu XL
    Bioorg Med Chem; 2010 Nov; 18(22):8035-43. PubMed ID: 20934346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-ligand interaction-based virtual screening for novel Eg5/kinesin spindle protein inhibitors.
    Nagarajan S; Skoufias DA; Kozielski F; Pae AN
    J Med Chem; 2012 Mar; 55(6):2561-73. PubMed ID: 22309208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors.
    Dong JJ; Li QS; Liu ZP; Wang SF; Zhao MY; Yang YH; Wang XM; Zhu HL
    Eur J Med Chem; 2013; 70():427-33. PubMed ID: 24184776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma.
    De Monte C; Carradori S; Secci D; D'Ascenzio M; Guglielmi P; Mollica A; Morrone S; Scarpa S; Aglianò AM; Giantulli S; Silvestri I
    Eur J Med Chem; 2015 Nov; 105():245-62. PubMed ID: 26498571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity.
    Woo HB; Eom YW; Park KS; Ham J; Ahn CM; Lee S
    Bioorg Med Chem Lett; 2012 Jan; 22(2):933-6. PubMed ID: 22222040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives.
    Abdelsalam MA; AboulWafa OM; M Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N; Elaasser MM
    Future Med Chem; 2018 May; 10(10):1159-1175. PubMed ID: 29787297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors.
    El-Hamamsy MH; Sharafeldin NA; El-Moselhy TF; Tawfik HO
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000060. PubMed ID: 32452567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted benzimidazoles: A novel chemotype for small molecule hKSP inhibitors.
    Lahue BR; Ma Y; Shipps GW; Seghezzi W; Herbst R
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3405-9. PubMed ID: 19481450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin KSP.
    Liu F; Yu LQ; Jiang C; Yang L; Wu WT; You QD
    Bioorg Med Chem; 2010 Jun; 18(12):4167-77. PubMed ID: 20537544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ATP-competitive kinesin spindle protein inhibitors.
    Parrish CA; Adams ND; Auger KR; Burgess JL; Carson JD; Chaudhari AM; Copeland RA; Diamond MA; Donatelli CA; Duffy KJ; Faucette LF; Finer JT; Huffman WF; Hugger ED; Jackson JR; Knight SD; Luo L; Moore ML; Newlander KA; Ridgers LH; Sakowicz R; Shaw AN; Sung CM; Sutton D; Wood KW; Zhang SY; Zimmerman MN; Dhanak D
    J Med Chem; 2007 Oct; 50(20):4939-52. PubMed ID: 17725339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents.
    El-Nassan HB
    Eur J Med Chem; 2013 Apr; 62():614-31. PubMed ID: 23434636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents.
    Carbajales C; Sawada JI; Marzaro G; Sotelo E; Escalante L; Sánchez-Díaz Marta A; García-Mera X; Asai A; Coelho A
    ACS Comb Sci; 2017 Mar; 19(3):153-160. PubMed ID: 28135059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New benzimidazoles and their antitumor effects with Aurora A kinase and KSP inhibitory activities.
    Abd El-All AS; Magd-El-Din AA; Ragab FA; ElHefnawi M; Abdalla MM; Galal SA; El-Rashedy AA
    Arch Pharm (Weinheim); 2015 Jul; 348(7):475-86. PubMed ID: 25900113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
    Ruan XQ; Chen M; Wu WT; You QD
    Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
    Yoon YK; Ali MA; Wei AC; Shirazi AN; Parang K; Choon TS
    Eur J Med Chem; 2014 Aug; 83():448-54. PubMed ID: 24992072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo design, synthesis and biological evaluation of 1,4-dihydroquinolin-4-ones and 1,2,3,4-tetrahydroquinazolin-4-ones as potent kinesin spindle protein (KSP) inhibitors.
    Jiang C; Yang L; Wu WT; Guo QL; You QD
    Bioorg Med Chem; 2011 Sep; 19(18):5612-27. PubMed ID: 21856161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
    Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
    Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, design, and synthesis of indole-based EZH2 inhibitors.
    Gehling VS; Vaswani RG; Nasveschuk CG; Duplessis M; Iyer P; Balasubramanian S; Zhao F; Good AC; Campbell R; Lee C; Dakin LA; Cook AS; Gagnon A; Harmange JC; Audia JE; Cummings RT; Normant E; Trojer P; Albrecht BK
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3644-9. PubMed ID: 26189078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.